DSGN – design therapeutics, inc. (US:NASDAQ)
Stock Stats
News
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Craig Hallum to a "strong-buy" rating.
Design Therapeutics (NASDAQ:DSGN) was upgraded by analysts at Leerink Partnrs from a "hold" rating to a "strong-buy" rating.
Design Therapeutics (NASDAQ:DSGN) is now covered by analysts at Craig Hallum. They set a "buy" rating on the stock.
Design Therapeutics (NASDAQ:DSGN) was given a new $14.00 price target on by analysts at Leerink Partners.
Design Therapeutics to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Form SCHEDULE 13D/A Design Therapeutics, Filed by: Logos Global Management LP
Form 144 Design Therapeutics, Filed by: Logos Global Master Fund LP
Form 144 Design Therapeutics, Filed by: Logos Global Master Fund LP
Form SCHEDULE 13D/A Design Therapeutics, Filed by: Logos Global Management LP
Form 144 Design Therapeutics, Filed by: Logos Global Master Fund LP
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.